Showing 11,141 - 11,160 results of 11,322 for search '(( six ((teer decrease) OR (a decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 0.50s Refine Results
  1. 11141

    DataSheet7_Guanxinkang Decoction Attenuates the Inflammation in Atherosclerosis by Regulating Efferocytosis and MAPKs Signaling Pathway in LDLR−/− Mice and RAW264.7 Cells.xlsx by Yifan Zhang (119570)

    Published 2021
    “…<p>Guanxinkang decoction (GXK), a traditional Chinese medicinal drug, is used to treat cardiovascular disease. …”
  2. 11142

    DataSheet6_Guanxinkang Decoction Attenuates the Inflammation in Atherosclerosis by Regulating Efferocytosis and MAPKs Signaling Pathway in LDLR−/− Mice and RAW264.7 Cells.ZIP by Yifan Zhang (119570)

    Published 2021
    “…<p>Guanxinkang decoction (GXK), a traditional Chinese medicinal drug, is used to treat cardiovascular disease. …”
  3. 11143

    DataSheet3_Guanxinkang Decoction Attenuates the Inflammation in Atherosclerosis by Regulating Efferocytosis and MAPKs Signaling Pathway in LDLR−/− Mice and RAW264.7 Cells.ZIP by Yifan Zhang (119570)

    Published 2021
    “…<p>Guanxinkang decoction (GXK), a traditional Chinese medicinal drug, is used to treat cardiovascular disease. …”
  4. 11144

    Data_Sheet_2_Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial Cells.xlsx by Souvarish Sarkar (8382513)

    Published 2020
    “…We validated progranulin (PGRN) as a lysosomal PD-associated protein that is downregulated by αSyn<sub>Agg</sub> in microglia in-vivo and is expressed by microglia in post-mortem PD brain, congruent with our in vitro findings.…”
  5. 11145

    DataSheet4_Guanxinkang Decoction Attenuates the Inflammation in Atherosclerosis by Regulating Efferocytosis and MAPKs Signaling Pathway in LDLR−/− Mice and RAW264.7 Cells.ZIP by Yifan Zhang (119570)

    Published 2021
    “…<p>Guanxinkang decoction (GXK), a traditional Chinese medicinal drug, is used to treat cardiovascular disease. …”
  6. 11146

    DataSheet5_Guanxinkang Decoction Attenuates the Inflammation in Atherosclerosis by Regulating Efferocytosis and MAPKs Signaling Pathway in LDLR−/− Mice and RAW264.7 Cells.ZIP by Yifan Zhang (119570)

    Published 2021
    “…<p>Guanxinkang decoction (GXK), a traditional Chinese medicinal drug, is used to treat cardiovascular disease. …”
  7. 11147

    DEG conditions and clusters. by Xiaoke Xu (3468623)

    Published 2024
    “…Our analysis revealed six distinct microglial clusters including homeostatic microglia, preactivated microglia, and activated microglia expressing high levels of inflammatory and disease-related molecules. …”
  8. 11148

    Infected cells in tissue and myeloid clusters. by Xiaoke Xu (3468623)

    Published 2024
    “…Our analysis revealed six distinct microglial clusters including homeostatic microglia, preactivated microglia, and activated microglia expressing high levels of inflammatory and disease-related molecules. …”
  9. 11149

    Supplementary Material for: Headache in Pediatric Moyamoya Disease after Revascularization Surgery by Yang J. (3341234)

    Published 2023
    “…We defined “headache associated with MMD” as the headache accompanied by a transient ischemic attack or provoked by hyperventilation. …”
  10. 11150

    Data_Sheet_1_Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial Cells.xlsx by Souvarish Sarkar (8382513)

    Published 2020
    “…We validated progranulin (PGRN) as a lysosomal PD-associated protein that is downregulated by αSyn<sub>Agg</sub> in microglia in-vivo and is expressed by microglia in post-mortem PD brain, congruent with our in vitro findings.…”
  11. 11151

    Myeloid cell comparison. by Xiaoke Xu (3468623)

    Published 2024
    “…Our analysis revealed six distinct microglial clusters including homeostatic microglia, preactivated microglia, and activated microglia expressing high levels of inflammatory and disease-related molecules. …”
  12. 11152

    Data Sheet 1_Exhaustion of NK cells and interferon activation in anti-MDA5+ dermatomyositis are associated and determine the development of ILD.docx by Chenyi Shao (6444911)

    Published 2025
    “…Flow cytometry confirmed significantly decreased NK cell counts and increased apoptosis in the ILD group. …”
  13. 11153

    DataSheet_1_AURKA inhibitor-induced PD-L1 upregulation impairs antitumor immune responses.docx by Bi Meng (16970205)

    Published 2023
    “…</p>Results<p>We found that AURKA inhibitor MLN8237 promoted the expression of PD-L1 in a time- and concentration-dependent manner while exerted its antitumor effect. …”
  14. 11154

    DataSheet8_Guanxinkang Decoction Attenuates the Inflammation in Atherosclerosis by Regulating Efferocytosis and MAPKs Signaling Pathway in LDLR−/− Mice and RAW264.7 Cells.docx by Yifan Zhang (119570)

    Published 2021
    “…<p>Guanxinkang decoction (GXK), a traditional Chinese medicinal drug, is used to treat cardiovascular disease. …”
  15. 11155

    Pathway analysis. by Xiaoke Xu (3468623)

    Published 2024
    “…Our analysis revealed six distinct microglial clusters including homeostatic microglia, preactivated microglia, and activated microglia expressing high levels of inflammatory and disease-related molecules. …”
  16. 11156

    Seq and cell summary. by Xiaoke Xu (3468623)

    Published 2024
    “…Our analysis revealed six distinct microglial clusters including homeostatic microglia, preactivated microglia, and activated microglia expressing high levels of inflammatory and disease-related molecules. …”
  17. 11157

    Image_1_Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recove... by Bernardo L. Rapoport (7431842)

    Published 2023
    “…This issue has been investigated in the current study in which alterations in the plasma concentrations of 16 soluble co-stimulatory and co-inhibitory, immune checkpoints were measured sequentially in a cohort of newly diagnosed, early BC patients (n=72), pre-treatment, post-NAC and post-surgery using a Multiplex<sup>®</sup> bead array platform. …”
  18. 11158

    Image_2_Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recove... by Bernardo L. Rapoport (7431842)

    Published 2023
    “…This issue has been investigated in the current study in which alterations in the plasma concentrations of 16 soluble co-stimulatory and co-inhibitory, immune checkpoints were measured sequentially in a cohort of newly diagnosed, early BC patients (n=72), pre-treatment, post-NAC and post-surgery using a Multiplex<sup>®</sup> bead array platform. …”
  19. 11159

    Image_5_Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recove... by Bernardo L. Rapoport (7431842)

    Published 2023
    “…This issue has been investigated in the current study in which alterations in the plasma concentrations of 16 soluble co-stimulatory and co-inhibitory, immune checkpoints were measured sequentially in a cohort of newly diagnosed, early BC patients (n=72), pre-treatment, post-NAC and post-surgery using a Multiplex<sup>®</sup> bead array platform. …”
  20. 11160

    Image_3_Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recove... by Bernardo L. Rapoport (7431842)

    Published 2023
    “…This issue has been investigated in the current study in which alterations in the plasma concentrations of 16 soluble co-stimulatory and co-inhibitory, immune checkpoints were measured sequentially in a cohort of newly diagnosed, early BC patients (n=72), pre-treatment, post-NAC and post-surgery using a Multiplex<sup>®</sup> bead array platform. …”